Stocks to Watch : SVRN, Inovio, Intel

AI Market Summary
The update is stock-specific: Inovio received FDA accelerated approval, SVRN faces a Nasdaq delisting notice, and Intel extended losses after disappointing earnings. For the listed universe, Intel is the relevant proxy. Read-through is limited, but the semiconductor weakness may weigh on sector sentiment near term.
Impact level
● Medium
Affected assets
NCSKINTC2USD/USDT-7.97%
AI Insight · NCSKINTC2USD/USDTAI Insight
▼ Bearish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
By Katherine Hamilton SVRN received a letter from Nasdaq stating that it no longer meets the terms necessary to be listed on the market. The stock slid 8% to $27.01 after the bell Friday.